75724 Paris CEDEX 15
France
Institut Pasteur - Virus & Immunity Unit
coronavirus; COVID-19; seroepidemiology; SARS-CoV-2; emerging infectious disease
SARS-CoV-2, breakthrough infection, hybrid immunity, immune trajectory, IgG4 class-switching, ADCC function
HIV-1, Env, gp41, MPER, broadly neutralizing antibody